-
Je něco špatně v tomto záznamu ?
Enhancing effect of cystamine in its amides with betulinic acid as antimicrobial and antitumor agent in vitro
U. Bildziukevich, L. Rárová, L. Janovská, D. Šaman, Z. Wimmer,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- Actinomyces účinky léků MeSH
- amidy chemie farmakologie MeSH
- antibakteriální látky chemická syntéza chemie farmakologie MeSH
- apoptóza účinky léků MeSH
- Bacillus cereus účinky léků MeSH
- Clostridium účinky léků MeSH
- cystamin chemie farmakologie MeSH
- kultivované buňky MeSH
- lidé MeSH
- mikrobiální testy citlivosti MeSH
- molekulární konformace MeSH
- proliferace buněk účinky léků MeSH
- protinádorové látky chemická syntéza chemie farmakologie MeSH
- screeningové testy protinádorových léčiv MeSH
- Streptococcus mutans účinky léků MeSH
- triterpeny chemie farmakologie MeSH
- vztah mezi dávkou a účinkem léčiva MeSH
- vztahy mezi strukturou a aktivitou MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Amides of betulinic acid with cystamine were synthesized to investigate their antimicrobial and antitumor activity, and their influence on the cell cycle and cell apoptosis. The former target amide (6) displayed cytotoxicity in CEM cell line after 72 h of treatment (IC50 = 3.0 ± 0.7 μM; TI = 20), and induced apoptosis by caspase-3/7 activation in CEM cells. The latter target amide (9) displayed antimicrobial activity against Streptococcus mutans (MIC 3.125 μM; MBC 3.125 μM) and Bacillus cereus (MIC 25 μM; MBC 25 μM). The achieved results demonstrate enhancing of their biological activity over that of the parent compounds. However, two intermediate compounds (2 and 7) displayed either considerable cytotoxicity (2; 7.5 ± 0.8 μM; TI = 10, against G361) or antimicrobial activity (7; both against Actinomyces odontolycus and Clostridium perfrigens with MIC 12.5 µM and MBC 12.5 µM). The experimental data were compared with the in silico calculated physico-chemical and ADME parameters of the target compounds, including successful intermediates.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20023802
- 003
- CZ-PrNML
- 005
- 20201214131242.0
- 007
- ta
- 008
- 201125s2019 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.steroids.2019.04.004 $2 doi
- 035 __
- $a (PubMed)31022408
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Bildziukevich, Uladzimir $u University of Chemistry and Technology, Department of Chemistry of Natural Compounds, Technická 5, 166 28 Prague 6, Czech Republic; Institute of Experimental Botany AS CR, v.v.i., Isotope Laboratory, Vídeňská 1083, 142 20 Prague 4, Czech Republic.
- 245 10
- $a Enhancing effect of cystamine in its amides with betulinic acid as antimicrobial and antitumor agent in vitro / $c U. Bildziukevich, L. Rárová, L. Janovská, D. Šaman, Z. Wimmer,
- 520 9_
- $a Amides of betulinic acid with cystamine were synthesized to investigate their antimicrobial and antitumor activity, and their influence on the cell cycle and cell apoptosis. The former target amide (6) displayed cytotoxicity in CEM cell line after 72 h of treatment (IC50 = 3.0 ± 0.7 μM; TI = 20), and induced apoptosis by caspase-3/7 activation in CEM cells. The latter target amide (9) displayed antimicrobial activity against Streptococcus mutans (MIC 3.125 μM; MBC 3.125 μM) and Bacillus cereus (MIC 25 μM; MBC 25 μM). The achieved results demonstrate enhancing of their biological activity over that of the parent compounds. However, two intermediate compounds (2 and 7) displayed either considerable cytotoxicity (2; 7.5 ± 0.8 μM; TI = 10, against G361) or antimicrobial activity (7; both against Actinomyces odontolycus and Clostridium perfrigens with MIC 12.5 µM and MBC 12.5 µM). The experimental data were compared with the in silico calculated physico-chemical and ADME parameters of the target compounds, including successful intermediates.
- 650 _2
- $a Actinomyces $x účinky léků $7 D000190
- 650 _2
- $a amidy $x chemie $x farmakologie $7 D000577
- 650 _2
- $a antibakteriální látky $x chemická syntéza $x chemie $x farmakologie $7 D000900
- 650 _2
- $a protinádorové látky $x chemická syntéza $x chemie $x farmakologie $7 D000970
- 650 _2
- $a apoptóza $x účinky léků $7 D017209
- 650 _2
- $a Bacillus cereus $x účinky léků $7 D001409
- 650 _2
- $a proliferace buněk $x účinky léků $7 D049109
- 650 _2
- $a kultivované buňky $7 D002478
- 650 _2
- $a Clostridium $x účinky léků $7 D003013
- 650 _2
- $a cystamin $x chemie $x farmakologie $7 D003538
- 650 _2
- $a vztah mezi dávkou a účinkem léčiva $7 D004305
- 650 _2
- $a screeningové testy protinádorových léčiv $7 D004354
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mikrobiální testy citlivosti $7 D008826
- 650 _2
- $a molekulární konformace $7 D008968
- 650 _2
- $a Streptococcus mutans $x účinky léků $7 D013295
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 650 _2
- $a triterpeny $x chemie $x farmakologie $7 D014315
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Rárová, Lucie $u Palacký University, Centre of the Region Haná for Biotechnological and Agricultural Research, Department of Chemical Biology and Genetics, Šlechtitelů 27, 783 71 Olomouc, Czech Republic.
- 700 1_
- $a Janovská, Lucie $u Palacký University, Department of Microbiology, Faculty of Medicine and Dentistry, Hněvotínská 3, 775 15 Olomouc, Czech Republic; Palacký University & Institute of Experimental Botany AS CR, Laboratory of Growth Regulators, Centre of the Region Haná for Biotechnological and Agricultural Research, Šlechtitelů 27, 783 71 Olomouc, Czech Republic.
- 700 1_
- $a Šaman, David $u Institute of Organic Chemistry and Biochemistry AS CR, v.v.i., Flemingovo náměstí 2, 166 10 Prague 6, Czech Republic.
- 700 1_
- $a Wimmer, Zdeněk $u University of Chemistry and Technology, Department of Chemistry of Natural Compounds, Technická 5, 166 28 Prague 6, Czech Republic; Institute of Experimental Botany AS CR, v.v.i., Isotope Laboratory, Vídeňská 1083, 142 20 Prague 4, Czech Republic. Electronic address: wimmerz@vscht.cz.
- 773 0_
- $w MED00004438 $t Steroids $x 1878-5867 $g Roč. 148, č. - (2019), s. 91-98
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31022408 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201214131241 $b ABA008
- 999 __
- $a ok $b bmc $g 1596121 $s 1114478
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 148 $c - $d 91-98 $e 20190422 $i 1878-5867 $m Steroids $n Steroids $x MED00004438
- LZP __
- $a Pubmed-20201125